Semistructured interviews with physicians and APPs detailed benefits, challenges, and adaptations involved in providing adolescent patients with access to patient portals.
Changes to prior authorization policies can increase the likelihood that patients will delay or stop filling prescriptions for oral anticancer drugs.
Researchers sought to determine whether consolidation with ASCT would be superior to radioimmunotherapy in patients with relapsed/refractory follicular lymphoma.
Patients with cancer, depression report acceptability of psilocybin-assisted therapy group model.
Researchers explored how rumination and core beliefs influenced patients’ psychological well-being after a cancer diagnosis.
A group of experts discussed alternative strategies for the development of CAR T-cell products in the context of pediatric cancer.
Jylamvo contains 2mg of methotrexate per mL and is packaged in bottles containing 60mL of oral solution.
Low platelet count, ISS III, higher WHO performance status, age older than 60 years are risk factors for severe infection/death.
Use of a digital patient monitoring tool showed high adoption and patient adherence among patients with lung or breast cancer.
The FDA has approved Avzivi (bevacizumab-tnjn), a biosimilar to Avastin (bevacizumab).
